|
PMN
|
1) Trivial maybe, our AD page https://www.promisneurosciences.com/product...
|
|
PMN
|
retiredcop wrote: Theses articles can be very useless from an investor...
|
|
PMN
|
Or, walk quietly and carry a big stick. Delivering the minimum pr to AAIC...
|
|
PMN
|
You may find this utube interesting then https://www.youtube.com/watch?v...
|
|
PMN
|
Interesting opinion of the "unabashedly scornful" comments (re ACH)...
|
|
PMN
|
Thanks RC, no doubt we'll get the grant value when the Weston foundation...
|
|
PMN
|
Promis is gradually moving toward a claim of exclusive or unique selectivity....
|
|
PMN
|
Hmm, the Cassava (SAVA) parallel is more interesting than I thought, well...
|
|
PMN
|
My concern is if they make it harder for anyone else to use NFL, if NFL even...
|
|
PMN
|
Biogen hunts accelerated approval for their ALS drug based on NFL biomarker...
|
|
PMN
|
Fine, they control the price. If that's all they want then listing now on...
|
|
PMN
|
Down on 20,000 shares or 1.2M pre-consolidation to start a no-news week in no...
|
|
PMN
|
retiredcop wrote: Upcoming AAIC ....I give it 5 minutes before the soap box...
|
|
PMN
|
So what do you think this buyer wants for the next 6 months? Not just what...
|
|
PMN
|
Thanks! It will be interesting to follow given the similar market cap...
|
|
PMN
|
Speculativefool wrote: ... no one in the industry thinks PMN is pursuing what...
|
|
PMN
|
The show must go on, the corporate state relies heavily on theatre. You'...
|
|
PMN
|
Yes, the lack of partnering is an issue. M&A not so much since no one is...
|
|
PMN
|
FarmerBetty wrote: Lot's of smart pharma people out there and if it was...
|
|
PMN
|
2 month vacation then back to chatter about P1 biomarkers q1-2 2023...
|